Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Trial of Insulin Glargine in Type 1 Diabetes
NCT00576862Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Primary endpoint: Evolution of efficacy parameters between first study visit (V1) and last study visit (V5) at 10 months. Started Nov 2002; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00576862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576862.